Items where Author is "Abdel-Fatah, TMA"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 13.

Journal article

ABDEL-FATAH, T.M.A., AGARWAL, D., LIU, D.X., RUSSELL, R., RUEDA, O.M., LIU, K., XU, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., REES, R.C., CALDAS, C., ELLIS, I.O., BALL, G.R. and CHAN, S.Y.T., 2016. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology, 17 (7), pp. 1004-1018. ISSN 1470-2045

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., CROTEAU, D.L., MOSELEY, P.M., HAMEED, K., GREEN, A., ALESKANDARANY, M.A., RAKHA, E.A., PATTERSON, K., BALL, G., CHAN, S.Y.T., ELLIS, I.O., BOHR, V.A., BRYANT, H.E. and MADHUSUDAN, S., 2015. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis, 37 (1), pp. 63-71. ISSN 0143-3334

ABDEL-FATAH, T.M.A., MCARDLE, S.E., AGARWAL, D., MOSELEY, P.M., GREEN, A.R., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2015. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research. ISSN 1078-0432

ALBARAKATI, N., ABDEL-FATAH, T.M.A., DOHERTY, R., RUSSELL, R., AGARWAL, D., MOSELEY, P., PERRY, C., ARORA, A., ALSUBHI, N., SEEDHOUSE, C., RAKHA, E.A., GREEN, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology, 9 (1), pp. 204-217. ISSN 1574-7891

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., MOSELEY, P.M., ALESKANDARANY, M.A., GREEN, A.R., BALL, G., ALSHAREEDA, A.T., RAKHA, E.A., CHAN, S.Y.T., ELLIS, I.O. and MADHUSUDAN, S., 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics, 14 (4), pp. 1057-1065. ISSN 1535-7163

ABDEL-FATAH, T.M.A., MIDDLETON, F.K., ARORA, A., AGARWAL, D., CHEN, T., MOSELEY, P.M., PERRY, C., DOHERTY, R., CHAN, S., GREEN, A.R., RAKHA, E., BALL, G., ELLIS, I.O., CURTIN, N.J. and MADHUSUDAN, S., 2015. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology, 9 (3), pp. 569-585. ISSN 1574-7891

ABDEL-FATAH, T.M.A., ARORA, A., MOSELEY, P., COVENEY, C., PERRY, C., JOHNSON, K., KENT, C., BALL, G., CHAN, S. and MADHUSUDAN, S., 2014. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers. BBA Clinical, 2, pp. 10-17. ISSN 2214-6474

ABDEL-FATAH, T.M.A., RUSSELL, R., AGARWAL, D., MOSELEY, P., ABAYOMI, M., PERRY, C., ALBARAKATI, N., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2014. DNA polymerase B deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts. Molecular Oncology, 8 (3), pp. 520-532. ISSN 1574-7891

PERRY, C., AGARWAL, D., ABDEL-FATAH, T.M.A., LOURDUSAMY, A., GRUNDY, R., AUER, D.T., WALKER, D., LAKHANI, R., SCOTT, I.S., CHAN, S., BALL, G. and MADHUSUDAN, S., 2014. Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era. Oncotarget, 5 (14), pp. 5764-5781. ISSN 1949-2553

ABDEL-FATAH, T.M.A., RUSSELL, R., ALBARAKATI, N., MALONEY, D.J., DORJSUREN, D., RUEDA, O.M., MOSELEY, P., MOHAN, V., SUN, H., ABBOTTS, R., MUKHERJEE, A., AGARWAL, D., ILLUZZI, J.L., JADHAV, A., SIMEONOV, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O., WILSON, D.M. and MADHUSUDAN, S., 2014. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Molecular Oncology, 8 (7), pp. 1326-1338. ISSN 1574-7891

ABDEL-FATAH, T.M.A., MCARDLE, S.E.B., JOHNSON, C., MOSELEY, P.M., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2014. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer, 110 (10), pp. 2450-2461. ISSN 1532-1827

ABDEL-FATAH, T.M.A., PERRY, C., DICKINSON, P., BALL, G., MOSELEY, P., MADHUSUDAN, S., ELLIS, I.O. and CHAN, S.Y.T., 2013. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology, 24 (11), pp. 2801-2807. ISSN 1569-8041

ABDEL-FATAH, T.M.A., ALBARAKATI, N., BOWELL, L., AGARWAL, D., MOSELEY, P., HAWKES, C., BALL, G., CHAN, S., ELLIS, I.O. and MADHUSUDAN, S., 2013. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Research and Treatment, 142 (3), pp. 515-527. ISSN 0167-6806

This list was generated on Fri Nov 17 21:31:15 2017 UTC.